Mario Javier Pineda

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Robert J. Morgan, Deborah K. Armstrong, Ronald D. Alvarez et al. · Journal of the National Comprehensive Cancer Network · 2016 · 318 citations · Full text

Cancer Management, Gynecology, Pathology +18

Safety and dose modification for patients receiving niraparib

Jonathan S. Berek, Ursula A. Matulonis, Ulla Peen et al. · Annals of Oncology · 2018 · 183 citations

Role of two upstream open reading frames in the translational control of oncogene mdm2

Cheryl Y. Brown, Gregory J. Mize, Mario Javier Pineda et al. · Oncogene · 1999 · 111 citations

Natural Sciences, Molecular Biology, Dna Replication +3

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial

Michel Fabbro, Kathleen N. Moore, Anne Dørum et al. · Gynecologic Oncology · 2019 · 48 citations · Full text

A TRIM5α-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry

Mario Javier Pineda, Brannon R. Orton, Julie Overbaugh · Virology · 2007 · 31 citations · Full text

Viral Persistence, Human Retrovirus, Trim5α-independent Post-entry Restriction +11